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Lack of physical exercise is considered an important risk factor for chronic diseases. On the contrary, physical exercise reduces the
morbidity rates of obesity, diabetes, bone disease, and hypertension. In order to gain novel molecular and cellular clues, we analyzed
the effects of physical exercise on differentiation of mesenchymal circulating progenitor cells (M-CPCs) obtained from runners. We
also investigated autophagy and telomerase-related gene expression to evaluate the involvement of specific cellular functions in the
differentiation process. We performed cellular and molecular analyses in M-CPCs, obtained by a depletion method, of 22 subjects
before (PRE RUN) and after (POST RUN) a half marathon performance. In order to prove our findings, we performed also in vitro
analyses by testing the effects of runners’ sera on a human bone marrow-derived mesenchymal stem (hBM-MSC) cell line. PCR
array analyses of PRE RUN versus POST RUN M-CPC total RNAs put in evidence several genes which appeared to be
modulated by physical activity. Our results showed that physical exercise promotes differentiation. Osteogenesis-related genes as
RUNX2, MSX1, and SPP1 appeared to be upregulated after the run; data showed also increased levels of BMP2 and BMP6
expressions. SOX9, COL2A1, and COMP gene enhanced expression suggested the induction of chondrocytic differentiation as
well. The expression of telomerase-associated genes and of two autophagy-related genes, ATG3 and ULK1, was also affected and
correlated positively with MSC differentiation. These data highlight an attractive cellular scenario, outlining the role of
autophagic response to physical exercise and suggesting new insights into the benefits of physical exercise in counteracting
chronic degenerative conditions.
1. Introduction
Lack of physical exercise is considered an important risk
factor for chronic diseases. On the contrary, physical exer-
cise counteracts obesity, diabetes, bone disease, and hyper-
tension [1] as well as other degenerative diseases [2, 3]. In
addition, physical exercise plays a central role in maintain-
ing bone quality [4]. Recently, we identified several pro-
teins differentially expressed in runners’ sera after the
half marathon. Despite several negative cellular effects,
such as oxidative stress, the resulting proteome modula-
tion seems to be beneficial for the overall health [5]. We
also demonstrated that running the half marathon
increases the expression of the osteogenic transcription
factor RUNX2 as well as the calcification process in an
in vitro model. Furthermore, we found a reduction in
the adipogenic commitment of a human bone marrow-
derived mesenchymal stem cell (hBM-MSC) line treated
with sera obtained from runners [5]. MSCs, together with
hematopoietic, endothelial, and smooth or skeletal muscle
precursors can be found in peripheral blood as circulating
progenitor cells (CPCs) [6, 7]. In the past, we have
described the isolation of MSC-like cells from peripheral
blood (CD3-, CD19-, CD14low, CD45low, and CD34low),
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characterized by clonogenic growth and differentiation
ability [8]. In addition, these mesenchymal circulating pro-
genitor cells (M-CPCs) expressed also CD105 and CD73
markers [9]; we have investigated their involvement in
various skeletal degenerative diseases [9–12]. Considering
the clinical and social impact of common skeletal degener-
ative diseases such as osteoporosis and ostearthrosis, we
were interested to evaluate the effects of physical activity
on M-CPCs. Since during physical activity oxidative stress
as well as pleiotropic cytokine production increases, we
hypothesized that different biological processes involved
in differentiation might be affected in progenitor cells. In
particular, telomerase activity and autophagy, which are
both involved in oxidative stress [13–15], have been suggested
as biological processes affecting differentiation [16, 17].
Therefore, we hypothesized that physical activity might pro-
mote differentiation by regulating telomerase-associated
genes as well autophagy.
Several studies have demonstrated that the progenitor
cell number increases in peripheral blood in response to
endurance and physical exercise [18–21]. Various kinds of
exercise such as running, rowing, and cycling may stimulate
progenitor cell mobilization; stimulation of stem cell forma-
tion sites, such as the pelvis and femur, can be considered
responsible for this [19, 22]. Inflammation-related [5, 23]
or adrenaline-induced factors [24] might affect progenitor
cell mobilization during exercise. However, the proliferative
potential of MSCs declines with age because of telomere
shortening [25, 26]. In addition, telomeres can be affected
by genotoxic injuries and oxidative stress [27]. Notably,
short telomeres affect the proliferation, self-renewal, and
commitment of progenitor cells [28] and induce alterations
during their differentiation process in embryonic stem cells
[16]. However, while telomere length is important to coun-
teract mesenchymal stem cell senescence, [29], telomerase
activity plays an important role in the differentiation
process [30]. Increased telomerase activity due to the over-
expression of human telomerase reverse transcriptase
(hTERT) gene in hMSCs promotes osteoblast differentia-
tion in vitro as well as heterotopic bone formation in vivo
[31, 32]. Besides maintaining telomere length, hTERT
increases stem cell proliferation, rescues the impaired dif-
ferentiation, and, in this way, counteracts senescence-
induced negative effects [32]. Senescence may be spurred
by autophagy deregulation leading to intracellular waste
accumulation [33]. Autophagy plays an important role in
differentiation and stemness regulation of various cellular
types, including MSCs [17]. Its activation has been
suggested to counteract bone loss [34] as well as MSC
senescence [35]. Autophagy also regulates adipocyte differ-
entiation and lipid accumulation and plays an important
role in the balance between white and brown fat [36]. Con-
versely, impaired autophagy in MSCs can induce metabolic
diseases [35, 37–39]. Thus, autophagy is considered an “anti-
aging dynamic system” because of its contribution to cell
renewal and homeostasis [40]. It has been reported that
telomerase regulates autophagy [41, 42]; an increase in
telomerase activity and autophagy has been demonstrated
following calorie restriction [43].
The aim of this study was to understand whether physical
activity may promote osteogenic differentiation of CPCs. We
investigated the involvement of cellular processes such as
autophagy and telomere maintenance in osteogenic differen-
tiation by means of PCR array analysis.
Therefore, in order to better understand the effects of
physical activity on M-CPCs, we investigated their commit-
ment as well as their modulation of telomerase-related genes,
following the half marathon. We evaluated the effects of half
marathon also on the autophagic process, as a supposed
mechanism influencing M-CPC differentiation. In addition,
we performed in vitro experiments supporting our findings.
2. Materials and Methods
2.1. Subjects. 22 male runners and 10 age-matched male con-
trols were included in the study (Figure 1). Study subjects
were healthy and regularly active. Participants were enrolled
during sport events called “run for science,” held in Verona
(Italy) in April 2016 and April 2017. Twenty-two male run-
ners (median age: 45, 4 ± 11; median BMI: 22.6) carried out
a 21.1km half marathon in 1:40 ± 0:44 hours. Participants
were all recreational runners and physically fit, with a median
training regimen in the last 10 years: 220 minute/week and
with an estimated mean VO2 max of 44.9 at the end of the
run, classified as great for males with similar mean age
[44]. Controls have median age of 44, 7 ± 12, median BMI
of 24.2, and estimated VO2 of 36-41 [45, 46] and had not
been training for 13:4 ± 2 years. All runners and controls
underwent a clinical evaluation and a medical history inter-
view in order to exclude comorbidities or drug intake.
Blood was collected from controls and runners at the
same time of day. Blood samples, obtained by venipuncture,
were collected immediately before and 15min after the run,
respectively. Written informed consent was obtained from
all participants, and the study was approved by the ethical
committee of Azienda Ospedaliera Universitaria Integrata of
Verona, Italy (number 1538; Dec. 3, 2012; local ethical com-
mittee of Azienda Ospedaliera Integrata di Verona). The study
design and methods comply with the Declaration of Helsinki.
Biochemical analyses were performed before and after the
run: s-calcium (Ca), s-phosphate (P), carboxy-terminal telo-
peptide of type I collagen (CTX), ferritin, and chlorine (Cl)
were monitored; 25-hydroxy vitamin D (vitD) was also eval-
uated in order to exclude vitD-deficient individuals.
2.2. Serum Collection. In order to evaluate the effects of sera
in vitro, we collected PRE and POST RUN sera from 10ml
of fresh blood by centrifugation at 400×g. Sera were har-
vested and frozen in aliquots at −80°C until use. To perform
the in vitro experiments, individual PRE RUN sera and
POST RUN sera, respectively, were pooled.
2.3. Circulating Progenitor Cells (CPCs). To evaluate differen-
tiation ability and modulation of telomerase-related genes,
we isolated M-CPCs from heparinized blood as previously
reported [11]. In particular, M-CPCs were collected from
50ml of heparinized blood by a depletion method, performed
by two Ficoll procedures in order to remove hematopoietic
cells using the antibody cocktail. Initially, peripheral blood
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mononuclear cells (PBMCs) were isolated by a gradient cen-
trifugation at 800×g for 30min at 20°C (first Ficoll proce-
dure). Then, to remove the unwanted hematopoietic cells, a
RosetteSep antibody cocktail (Stemcell Technologies Inc.,
Vancouver, Canada) was used with 5ml of whole blood
mixed with the PBMCs obtained by the first Ficoll. The anti-
body cocktail (against CD3, CD14, CD19, CD38, and
CD66b-positive cells), at dilution of 50 μl/ml, was incubated
with samples for 20min at room temperature. Finally, a sec-
ond Ficoll procedure was performed to remove the unwanted
cells linked to antibody cocktail and crosslinked to red blood
cells (glycophorin A). Collected cells were then washed in
phosphate-buffered saline (PBS). Phenotype analysis was
performed as previously described [9].
2.4. Analysis of Cell Phenotype. We evaluated the phenotype
of M-CPCs by analyzing the gene expression for CD3,
CD14, CD19, CD45, CD34, CD73, and CD105 markers, as
reported previously [9]. This method allows the analysis of
cell phenotype when stringent purification strategies are per-
formed [47].
2.5. In Vitro Osteogenic and Adipogenic Differentiation. Sera,
obtained from each runner before and after the competition,
were mixed in two pools named PRE RUN and POST RUN
sera, respectively. In order to study the induction of osteo-
genic and adipogenic differentiation, respectively, before
and after physical exercise, we treated the BM-hMSC cell line
(human bone marrow-human mesenchymal stem cells,
PromoCell, Heidelberg, Germany) with pooled PRE RUN
and POST RUN sera [5].
Pooled sera were added to the above cell line at 10% final
concentration. Cells were plated at a density of 5 × 104 cells
per well into 24-well plates and cultured up to 21 days. In
particular, osteogenic differentiation was performed with
osteogenic medium containing osteogenic stimulatory
supplements (15%, Stemcell Technologies Inc., Vancouver,
Canada), 10−8M dexamethasone, 3.5mM β-glycerophos-
phate, and 50 μg/ml ascorbic acid (Stemcell Technologies
Inc.). The adipogenic differentiation was performed by using
0.5mM isobutylmethylxanthine, 200 μM indomethacin,
10−6M dexamethasone, and 10μg/ml insulin in basal
medium. Chondrogenic differentiation was performed by
culturing hMSCs with mesenchymal stem cell chondrogenic
differentiation medium (PromoCell, Heidelberg, Germany).
For osteogenic, adipogenic, or chondrogenic differentiation,
the medium was changed every 3 days after initial plating.
2.6. Total RNA Extraction and Reverse Transcription. Pellets
from the differentiated BM-hMSC cell line treated with
pooled sera and from CPCs were collected and stored at
-80°C. Then, they were processed for RNA extraction with a
“RNeasy® protect mini kit” by Qiagen, Hilden, Germany, fol-
lowing the manufacturer’s protocol. RNA samples were
quantified by a Qubit™ 3 fluorometer using a “Qubit™
RNA HS assay kit” (Invitrogen, Carlsbad, USA). Two micro-
grams of the extracted RNAs was reverse transcribed with a























Figure 1: A schematic view describing the work flow and connections between the data obtained by investigations performed in vivo (a) and
in vitro (b).
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Chalfont, UK, according to the producer’s instructions. RNA
and cDNA samples were stored at -80°C.
2.7. PCR Array. PCR arrays were performed by using
TaqMan™ array human osteogenesis (Thermo Fisher Cor-
poration, Waltham, MA, USA, 4414096) and TaqMan™
array human telomere extension by telomerase (Thermo
Fisher Corporation, Waltham, MA, USA, 4414187) accord-
ing to the manufacturer’s instructions.
2.8. Real-Time RT-PCR. To validate the array profile of M-
CPCs as well as to investigate gene expression modulation in
M-CPCs and in in vitro experiments, we performed real-time
PCR analyses as reported previously [10]. Briefly, predesigned,
gene-specific primers and probe sets for each gene (CD3,
hs00174158_m1; CD14, hs02621496-s1; CD19, hs00174333_
m1; CD45, hs00174541_ m1; CD34, hs00156373_m1; CD73,
hs00159686_m1; CD105, hs00923996_m1; RUNX2,
hs00231692_m1; OSTERIX (SP7), hs00541729_m1; COLLA-
GEN,TYPE I, ALPHA2 (COL1A2), hs01028956_m1;OSTEO-
NECTIN (SPARC), hs00234160_m1; OSTEOPONTIN (SPP1),
hs00167093_m1; BMP1, hs00241807-m1; BMP3, hs00609638-
m1; BMP4, hs03676628-s1; BMPR1A, hs1034913-g1; SOX9,
hs01107818_m1; COMP, hs004359-m1; MSX1, hs00427183-
m1; HNRNPA1, hs01656228-s1; MRE11a, hs00967437-m1;
RAD50, hs00990023-m1; TERF1, hs00819517-m1; TERT,
hs00972650-m1; COL2A1, hs00264051_m1; PPARG2,
hs01115513_m1; B2M, hs999999_m1 (housekeeping); and
GAPDH, 0802021 (housekeeping)) were obtained from
assay-on-demand gene expression products (Thermo
Fisher Corporation, Waltham, MA, USA). For autophagy
gene expression, we used the following SYBR green
primers: ATG3 FW GGAAGAATATGAAGAGAGTGG
RV CTCATCATAGCCAAACAACC, ATG7 FW AGAT
TGTCCTAAAGCAGTTG RV CCATACATTCACTGAG
GTTC, ULK1 FW TCAAAATCCTGAAGGAACTG RV
ACCAGGTAGACAGAATTAGC, and β-actin FW GATG
TATGAAGGCTTTGGTC RV TGTGCACTTTTATTGG
TCTC. Ct values for each reaction were determined using
TaqMan SDS analysis software (Applied Biosystems; Foster
City, California, USA) as reported previously. To calculate
relative gene expression levels between different samples,
we performed the analyses by using the 2−ΔΔCT method
and by using untreated MSC lines as calibrator.
2.9. Immunofluorescence. Immunofluorescence analyses were
performed to investigate osteogenic and adipogenic differen-
tiation or autophagy in in vitro experiments. After 21-day
culture, cells were fixed and processed according to the man-
ufacturer’s protocols. Primary antibodies were diluted (as
reported in the datasheet) in antibody dilution buffer and
incubated overnight at 4°C. To evaluate osteogenic differenti-
ation and autophagy, we used osteocalcin C8 antibody
(sc74495, Santa Cruz, Dallas, Texas, USA) and LC3B (cat.
#2775, Cell Signaling, Leiden, The Netherlands), respectively.
Assessment of adipogenic stimuli was achieved by testing
perilipin D1D8 (cat. #12589, Cell Signaling). Slides were then
incubated with secondary antibodies Alexa Fluor® 594
anti-rabbit (cat. #r37117), Alexa Fluor® 488 anti-rabbit
(cat. #a-11034), and goat mouse fluorescein conjugated
(cat. Ap124f, Millipore, Burlington, Massachusetts, USA).
Nuclear staining was performed by ProLong™ Gold Antifade
Mountant with DAPI. Images were recorded using a Leica
(Wetzlar, Germany) TCS SP5 AOBS inverted confocal
microscope at 63x. To express data in a semiquantitative
way, four different fields were measured for each sample,
in three independent experiments with about 80–100
total cells.
2.10. Western Blotting. To investigate protein levels related to
osteogenic, chondrogenic, and adipogenic differentiation or
to autophagy in in vitro experiments, we performed Western
blot analyses. Protein extraction was performed using RIPA
buffer (Thermo Fisher Scientific, Waltham, MA, USA)
according to the manufacturer’s protocol. A BCA assay
(Thermo Fisher Scientific, Waltham, MA, USA) was used to
determine protein concentrations. Protein samples were
diluted in 4x Laemmli’s sample buffer (Bio-Rad, CA, US),
heated for 5min at 95°C, and separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS PAGE),
using a mini-PROTEAN® TGX™ Precast gradient 4-20%
gel (Bio-Rad, CA, US), followed by transfer onto polyvinyli-
dene difluoride (PVDF) membranes (Thermo Fisher Scien-
tific, Waltham, MA, USA). PVDF membranes were probed
with the primary and secondary antibodies reported in
Table 1. Signals were detected using a chemiluminescence
reagent (ECL, Millipore, Burlington, MA, USA) according
to the manufacturer’s instructions. Images were acquired by
a LAS4000 Digital Image Scanning System (GE Healthcare,
Little Chalfont, UK). Densitometric analysis was per-
formed by using ImageQuant software (GE Healthcare,
Little Chalfont, UK), and the relative protein band inten-
sity was normalized to β-actin.
Table 1: Antibody list.
Antibody Ab dilution Origin Secondary antibody
ATG5 (D5F5U) 1 : 1000 Cell Signaling, 12994 Anti-rabbit (Cell Signaling, 7074)
LC3B 1 : 1000 Cell Signaling, 2775 Anti-rabbit (Cell Signaling, 7074)
Aggrecan (BC-3) 1 : 1000 Thermo Fisher Scientific Anti-mouse (Cell Signaling, 7076)
PLIN1 (D1D8) 1 : 1000 Cell Signaling, 12589 Anti-rabbit (Cell Signaling, 7074)
BMP2 1 : 1000 Proteintech, MCR, UK Anti-mouse (Cell Signaling, 7076)
COL1A1 (3G3) 1 : 200 Santa Cruz Biotech., Dallas, TX, USA Anti-mouse (Cell Signaling, 7076)
SQSTM1/P62 1 : 1000 Cell Signaling, 5114 Anti-rabbit (Cell Signaling, 7074)
β-actin (BA3R) 1 : 5000 Thermo Fisher Scientific, Waltham, MA, USA Anti-mouse (Cell Signaling, 7076)
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2.11. Alkaline Phosphatase Activity. To evaluate the activity
of alkaline phosphatase during osteogenic differentiation
in vitro, MSCs were cultured in the presence of either
PRE RUN or POST RUN sera. After 14 days of culture,
cytoplasmic ALP was analyzed by using the Alkaline
Phosphatase Kit 86-C (Sigma Aldrich GmbH, Munich,
Germany) as previously reported [48]. ALP activity was
calculated by multiplying the number of positive cells ×
the staining intensity value (from 0 to 4) in 100 total cells
according to the manufacturer’s instructions.
2.12. Alizarin Red Staining. To evaluate calcium deposition
during osteogenic differentiation in vitro, we performed
Alizarin red staining as previously described [8]. Briefly,
after 21 days of culture in the presence of osteogenic
medium, cells were fixed with 70% ethanol, washed three
times with water, and stained for 5min with 40mM Aliz-
arin red S at pH 4.1. Cells were then gently rinsed with 1x
phosphate-buffered saline for 15min. The area stained
with Alizarin red S was quantified in three independent
experiments by using ImageJ software (NIH, Bethesda,
MD, USA) as previously reported [49].
2.13. Oil Red O Staining. To evaluate the formation of lipid
droplets during adipogenic differentiation in vitro, we per-
formed Oil red O staining. The cells, cultured in adipogenic
medium with added PRE RUN and POST RUN sera, respec-
tively, were stained with Oil red O according to the manufac-
turer’s instructions. The total area of red pixels in the Oil red
O-stained droplets/cell was determined by using the ImageJ
analysis as previously reported [50]. In particular, means ±
SD of red stained areas, measured at 40x magnification, were
calculated in three different fields/slides and expressed as the
percentage compared to the total area.
2.14. Alcian Blue Staining. To evaluate chondrogenic differ-
entiation in in vitro experiments, we performed Alcian blue
staining after 21 days of culture as previously reported [12].
Briefly, the cells cultured in chondrogenic differentiation
medium and with PRE or POST RUN sera were fixed with
95% methanol and then stained with 1% Alcian blue 8GX
HCl overnight. Then, cell slides were washed and observed
under a microscope.
2.15. Statistical Analysis. Results were expressed as the
mean ± SD. Statistical analysis was assessed by Student’s
paired t-test. Differences with p < 0, 05 were considered sig-
nificant. We performed also correlation analyses by Pearson’s
test to measure linear dependence between the expression of
a single autophagy gene and the transcription factor RUNX2
or SOX9. For in vitro data, analyses were applied to experi-
ments carried out at least three times. Statistical analyses were
performed using SPSS for Windows, version 22.0 (SPSS Inc.,
Chicago, IL, USA).
3. Results
3.1. Biochemical Data. Results of biochemical evaluations in
sera collected before (PRE RUN) and after the run (POST
RUN) are reported in Table 2. None of the subjects showed
hypovitaminosis D at the baseline. Electrolytes, in particular,
sodium and potassium, showed significant variations due to
dehydration, as well as iron serum concentration. Ferritin
levels were also increased in POST RUN sera (p < 0:05).
3.2. Physical Exercise Promotes Mesenchymal Stem Cell
Differentiation.We evaluated the progenitor cells’ phenotype
as previously reported [12]. In Table 3, we reported the
Table 2: Biochemical data of the study population (22 runners).
Parameter PRE RUN (baseline values) (mean ± SD) POST RUN values (mean ± SD) p value
Age (yrs) 45:4 ± 11
Fe (mcg/dl) 15:15 ± 5:6 21:7 ± 6:39 p < 0:05
Mg (mg/dl) 0:84 ± 0:04 0:72 ± 0:05 p < 0:005
P (mg/dl) 1:12 ± 0:2 1 ± 0:2 NS
Ca (mg/dl) 2:4 ± 0:08 2:48 ± 0:11 NS
Na (mEq/l) 141 ± 0:87 144 ± 1:68 p < 0:001
K (mEq/l) 4:5 ± 0:27 4:84 ± 0:33 p < 0:05
Cl (mEq/l) 103 ± 1:13 103:8 ± 2:48 NS
Ferritin (ng/ml) 173 ± 170 198:7 ± 194 p < 0:05
CTx (ng/ml) −0:3 ± 0:128 0:36 ± 0:09 NS
25-OH vitamin D (ng/ml) 52:7 ± 10:18 — —
Table 3: Cell phenotype of cells harvested from 22 runners.
Cluster differentiation
transcript
PRE RUN (%) POST RUN (%) p value
CD105 66 ± 0:5 68 ± 0:6 NS
CD73 72 ± 0:3 71 ± 0:4 NS
CD3 0 0 NS
CD14 0:4 ± 0:05 0:5 ± 0:06 NS
CD19 0 0 NS
CD45 1:8 ± 0:4 1:9 ± 0:5 NS
CD34 Low level Low level NS
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expression of cluster differentiation (CD) of mesenchymal
cell phenotype (CD 105 and CD 73). In order to prove the
low hematopoietic contamination after depletion, we reported
also values of hematopoietic cell phenotype CDs. No pheno-
typical difference was observed between PRE RUN- and POST
RUN-selected cells. In order to evaluate if physical exercise
induces mesenchymal differentiation in circulating progeni-
tors, we analyzed the differentiation profiles in PRE RUN
and POST RUN CPCs by the osteogenesis array and subse-
quent RT real-time PCR.
The fold changes of gene expression (Figure 2(a))
obtained by the osteogenesis array are listed in Supplemental
Table 1.
In order to validate these findings, we performed RT real-
time PCR assays for several genes. We investigated the
expression of SP7, the RUNX2 downstream gene, as well.
Most of the investigated genes were expressed at
higher levels in POST RUN M-CPCs compared to PRE
RUN M-CPCs (Figure 2(b)). The higher expression levels
indicated a strong commitment of M-CPCs to osteogenic dif-
ferentiation. In particular, RUNX2 expression in POST RUN
was >3-fold higher compared to PRE RUN CPCs (p < 0:01);
RUNX2 downstream genes COL1A2 (p < 0:05), SPARC
(p < 0:05), SP7 (p < 0:05), and SPP1 (p < 0:01) in turn con-
firmed the osteogenic trend, as their expression was higher too.
However, we observed lower POST RUN expression
levels of BMP4 (p < 0:05) and BMPR1a (p < 0:05), compared
to PRE RUN levels. Ten controls were also included in the
study, in order to monitor any bias due to technical proce-
dures. In control samples obtained at time 0 and after 2 hrs,
no differences were observed in gene expression evaluated
by RT real-time PCR (Figure 1S).
Considering that the observed modulation in CPCs might
be induced by circulating factors, we then tested the effects of
sera in in vitro experiments. We analyzed the effects of PRE
RUN and POST RUN sera on a hBM-MSC line. Findings
from the MSC line culture supplemented with runners’ sera
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Figure 2: Expression levels plotted for 68 genes evaluated by TaqMan™ Human Osteogenesis Array in M-CPCs (a). Real-time PCR single
assay validation of BMP1, BMP3, BMP4, BMPR1A, COL1A2, COMP, MSX1, RUNX2, SOX9, SPARC, and SSP1 was performed in M-
CPCs of runners (b). Fold change of gene expression is reported as normalized 2−ΔΔCT values. ∗p < 0:05; #p < 0:01. In blue: PRE RUN; in
red: POST RUN.
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expression profiles (after 7 days of culture for RUNX2 and
after 14 days of culture for SPP1 and SPARC) (Figure 3(a)),
alkaline phosphatase activity (Figure 3(b)), COL1A1 and
BMP2 protein expression (Figure 3(c)), osteocalcin expres-
sion (Figure 3(d)), and calcium deposition (evaluated by
Alizarin red staining) (Figure 3(e)) indicated the increased
osteogenic differentiation and maturation of cells treated
with POST-RUN sera.
To investigate the chondrogenic commitment in M-
CPCs, we analyzed the expression of SOX9 transcription
factor and of the cartilage-specific COL2A1 and COMP genes
by RT real-time PCR. In particular, the higher expression of
COL2A1 (p < 0:01) as well as of COMP (p < 0:05) in POST
RUN M-CPCs confirmed the clues obtained from the chon-
drogenic determinant SOX9 (p < 0:05) (Figure 4(a)). The
hBM-MSC line supplemented with runners’ sera confirmed
the enhanced chondrogenic differentiation when cells were
cultured in the presence of POST RUN sera. The increased
expression of chondrogenic genes (SOX9 after 7 days of
culture; COL2A1 and COMP after 14 days of culture)
(Figure 4(b)) of Aggrecan protein (Figure 4(c)) as well as
stronger Alcian blue staining (Figure 4(d)) was detected in
cultures supplemented with POST RUN sera.
To evaluate M-CPC adipogenic commitment, we ana-
lyzed the expression of the adipogenic transcription factor
PPARG2. Data obtained by RT real-time PCR showed that
the PPARG2 gene expression was higher in POST RUN
M-CPCs (Figure 4(e)) (p < 0:05). No variations were
observed in the expression of the above genes in progeni-
tor cells from controls (Figure S2). However, when we treated
the hBM-MSC line with POST RUN sera, PPARG2 gene
expression levels (after 7 days of culture) were lower
compared to those observed with PRE RUN serum treatment
(Figure 4(f)) (p < 0:05). These latter data were confirmed by
Oil red O staining of cells after 14 days of culture: a reduction







































































































































Figure 3: Effects of sera on a mesenchymal stem cell line. Gene expression profiles confirmed the osteogenic commitment observed in M-
CPCs (a); ALP activity (b) and COL1A1 and BMP2 protein expression (c) as well as osteocalcin-positive cells (10x, inset 60x) (d); calcium
deposition, evaluated by Alizarin red staining (10x) (e), indicated the increased osteogenic maturation of cells treated with POST RUN
sera. The in vitro analyses were performed in three independent experiments, ∗p < 0:05.
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PLIN1-positive cells (Figure 4(h)) as well as lower PLIN1
protein levels (Figure 4(i)) were observed.
We did not observe any effects related to osteogenic, adi-
pogenic, or chondrogenic differentiation in the hBM-MSC
line treated with control sera (Figure 3S).
3.3. Physical Exercise Affects the Expression of Telomerase-
Associated Genes and Enhances Autophagy. We analyzed
the expression of telomerase-associated genes and autophagy-
related genes in order to evaluate the involvement of these
cellular processes in the differentiation of circulating progen-
itors following physical exercise. Telomerase-associated
genes, evaluated by gene array analysis in M-CPCs, were
differentially expressed after physical exercise (p < 0:01)
(Figure 5(a)). Supplemental Table 2 reports in detail POST-
































































































































































































































































































































Figure 4: Physical exercise improves chondrogenic differentiation and affects adipogenic differentiation. Besides SOX9 upregulation, we
observed also a higher expression of COL2A1 and COMP in M-CPCs after the run (a). In vitro experiments showed an increased
chondrogenic differentiation in the MSC line cultured in the presence of POST RUN sera. In fact, a higher expression of chondrogenic
genes (b) and of Aggrecan protein (c) as well as more intense Alcian blue staining ((d); 10x) was observed. Adipogenic differentiation.
PPARG2 gene expression was higher in POST RUN M-CPCs (e). Conversely, the MSC line treated with POST RUN sera showed reduced
adipogenic differentiation. In fact, PPARG2 gene expression levels were lower (f); the number of lipid droplets ((g); 10x) and of PLIN1-
positive cells ((h); 40x) as well as PLIN1 protein levels (i) was reduced in the MSC line treated with POST RUN sera. The in vitro analyses
were performed in three independent experiments. ∗p < 0:05; #p < 0:01.
8 Oxidative Medicine and Cellular Longevity
Thereafter, we performed RT real-time PCR assays to val-
idate the array data, which were confirmed as shown in
Figure 5(b). Notably, both TERT and TERF1 POST RUN
expression levels were higher than PRE RUN levels (p < 0:01),
while POST RUN expression levels of several DNA repair
genes (e.g., RAD50 and HNRNPA1) were lower (p < 0:05).
No differences were observed in controls (Figure 4S).
Finally, we investigated the expression of autophagy-
related genes, in order to gain information about the physical
exercise-induced modulation of this vital cellular process. We
analyzed ATG3, ATG7, and ULK1, in PRE and POST RUN
M-CPCs. Autophagy-related genes appeared to be upregu-
lated in POST RUNM-CPCs (Figure 6(a)) whereas no differ-
ences were found in controls (Figure 5S).
To confirm these findings, we treated a hBM-MSC line
with PRE and POST RUN sera. We found that cells treated
with POST RUN sera expressed lower levels of the autopha-
gic flux marker p62 and higher ATG5 and LC3 levels, respec-
tively, compared to cells treated with PRE RUN sera
(Figures 6(b) and 6(c)).
Interestingly, by using Pearson’s correlation test, we
found a positive correlation between ATG3 and SOX9
expression (r = 0:95) and ATG3 and RUNX2 expression
(r = 0:98). Similarly, positive correlations between ULK1
and SOX9 expression (r = 0:96) and ULK1 and RUNX2
expression (r = 0:97) were observed.
4. Discussion
Our findings call for some comments on the biological effects
of half marathon. Biochemical evaluations showed a signifi-
cant increase of iron levels, possibly related to tissue injury,
as previously suggested [51], while the increased ferritin
levels might be attributed to the inflammatory process related
to the run. However, the increased serum ferritin levels point
also towards the autophagic process activation in response to
physical activity. In fact, it has been demonstrated that serum
ferritin is secreted from macrophages by an “atypical” vesic-
ular system involving the autophagic process [52]. In partic-
ular, ferritin gets into the endolysosomal system via NCOA4
autophagy receptor [53]. Therefore, autophagy is involved in
the regulation of cellular redox status modulated by physical
activity [54], through the degradation of iron-binding pro-
teins such as ferritin [55].
In this study, we also confirmed the role of physical
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Figure 5: Fold change of gene expression plotted for 19 genes evaluated by TaqMan™ Human Telomerase Array in pooled M-CPCs of
runners (a). In M-CPCs of runners, we performed real-time PCR single assay validations of HNRNPA1, MRE11A, RAD50, TERF1, and
TERT (b). Fold change of gene expressions is reported as normalized 2−ΔΔCT values. ∗p < 0:05; #p < 0:01.
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for the first time, we reported osteogenic gene expression
modulation during physical activity. The expression of most
osteogenesis-related genes, namely, RUNX2, MSX1, and
SPP1, appeared upregulated after running. Array data
showed increased levels of BMP2 and BMP6, according to
their role in promoting osteogenesis [56]. The in vitro effects
of sera on the hBM-MSC line confirmed the enhanced oste-
ogenic differentiation due to physical exercise. On the other
hand, the observed lower expression of BMP4 in M-CPCs
was intriguing: it might be explained considering that
BMP4 plays a dual role both in adipogenesis and in metabo-
lism [57]. Consistently, we observed a downregulation of
BMPR1a gene in POST RUNM-CPCs, as BMP4 signal trans-
duction is mediated by BMPR1a receptor [58]. In addition, it
has been demonstrated that BMP4 reduces PPARG2 and
increases PPARG1 expression in order to drive the terminal
differentiation to white-like adipocyte at brown adipocyte’s
expense [59]. Indeed, we observed an increased expression
of PPARG2 in M-CPCs. This finding is in agreement with
the role of PPARG2 in regulating insulin sensitivity and glu-
cose utilization as well as energy homeostasis [60]. Con-
versely, we did not observe increased PPARG2 gene
expression in the hBM-MSC line treated with POST RUN
sera. In addition, the number of lipid droplets as well as
PLIN1 protein levels was reduced in MSCs treated with
POST RUN sera suggesting that physical activity modulates
negatively adipogenic differentiation. Moreover, we observed
a higher expression of BMP3 after the athletic performance.
Unlike BMP2 and BMP6, BMP3 reduces osteogenesis; it also
promotes preadipocyte proliferation by activating the
TGFbeta/ACTIVIN-signaling pathway. Interestingly, we
have previously demonstrated that physical exercise modu-
lates miRNA expression in progenitor cells promoting osteo-
genesis [61]. Otherwise, by acting on WISP1, BMP3
stimulates MSC proliferation [62]. This finding explains our
results related to the expression of both TERT and TERF1
genes which was higher in M-CPCs after the run. We assume


































































































Figure 6: Physical exercise induced the upregulation of autophagy-related genes inM-CPC (a). To confirm this finding, we treated aMSC line
with PRE RUN and POST RUN sera and we analyzed p62, ATG5, and LC3 expression. As shown in (b), MSCs treated with POST RUN sera
expressed lower p62 and higher ATG5 and total LC3 (both LC3I and LC3II) protein levels compared to cells treated with PRE RUN sera. This
last finding was confirmed by analyzing the number of cells expressing LC3 (c), evaluated by a fluorescence confocal microscope, 63x. In vitro
analyses were performed in three independent experiments, ∗p < 0:05; #p < 0:01.
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cells by enhancing their proliferation and by inducing their
commitment and differentiation. It is worth mentioning that
hTERT plays an important role among the cellular processes
affecting osteogenic differentiation [31, 32]. Murine MSCs
with knock-down telomerase activity cannot differentiate
into adipocytes or chondrocytes [63] while telomerase-
overexpressing cells have an increased osteogenic ability
[32]. However, TERT expression in MSCs is debatable. It is
known that telomerase activity is reduced in differentiating
progenitor cells with reduced proliferative ability [30]. Telo-
merase levels in MSCs are low or absent [64] and can be
upregulated by stimuli [30]. Interestingly, among the stimuli
inducing telomerase expression, oxidative stress plays an
important role [65]. Therefore, the increased telomerase
expression observed in POST RUN CPCs could be due to
the oxidative stress following physical activity.
In addition, in POST RUN M-CPCs, we observed the
upregulation of genes associated with chondrogenic differen-
tiation such as SOX9, COMP, and COL2A1. The in vitro
experiments confirmed these findings. These data not only
demonstrate that physical exercise induces progenitor cell
commitment to the chondrogenic lineage but also suggest
that chondrocytic maturation is accomplished. We cannot
exclude that the PRE RUN and POST RUN changes observed
in gene expression result from the recruitment of different
cell types. However, it has been reported that the amount of
M-CPCs is not influenced by physical activity [6], at least
immediately after the athletic performance. In fact, it has
been reported that bone marrow MSC number increases fol-
lowing physical activity [21]. Therefore, we can speculate that
an extension of the observation interval might disclose an
increased number of M-CPCs.
In M-CPCs, we observed an increased expression of
genes related to autophagy, an important process involved
in osteogenic differentiation [66]. These data were confirmed
in vitro. In fact, positive LC3 cells and total LC3 (LC3I
+LC3II) as well as ATG5 protein expression increased while
p62 decreased in MSCs treated with POST RUN sera. This
finding is in agreement with our previous study where we
observed, by proteomic analysis of runners’ sera, the overex-
pression of Von Willebrand factor (VWF) after physical
exercise [5]. Indeed, it has been demonstrated that autophagy
regulates endothelial cell secretion of VWF [67]. This evi-
dence supports the observed elevated ferritin levels in sera
after physical activity; we assume that a strong induction of
autophagy may occur during an endurance trial in various
cell types. Moreover, we observed a positive correlation
between ATG3 and ULK1 gene expression and SOX 9 and
RUNX2 gene expression in circulating progenitors. The
above observations highlight the positive effect of autophagy
on the chondrogenic and osteogenic differentiation, respec-
tively; moreover, we assume that autophagy was enhanced
by physical exercise as a protective mechanism in response
to oxidative stress. Thus, induced autophagy promoted pro-
genitors’ chondrogenic and osteogenic differentiation. Inter-
estingly, it has been demonstrated that telomerase regulates
the autophagic process through a glycolysis enzyme (HK2)
involved in the catabolism from glucose to glucose-6-
phosphate [41].
In summary, we suppose that the increased expression of
chondrogenic and osteogenic genes in M-CPCs following
exercise is due to enhanced autophagy. On the other hand,
PPARG2 gene-increased expression is a consequence of insu-
lin signaling modulation that occurs during physical activity.
Interestingly, besides the upregulation of autophagy and
telomerase-associated genes, we observed downregulation
of several DNA repair-related genes. This is a peculiar result
since it is known that autophagy may induce either cell sur-
vival or apoptosis on the basis of the genomic damage extent
[68]. A reduced availability of proteins involved in DNA
repair induces apoptosis [69]. It is known that stem cells
respond to DNA damage by activating the DNA repair sys-
tems [70, 71]. DNA repair is important for cell survival, while
it may lead as well to the accumulation of genomic alterations
in stem cells. Moreover, it has been shown that DNA repair
activity changes from undifferentiated to differentiated
hMSCs [72]. In fact, undifferentiated adult hMSCs have
higher repair activity and are resistant to radiation, while pre-
differentiated hMSCs may be sensitive to radiation and
undergo apoptosis.
Considering this complex background, we conclude that
physical exercise, e.g., half marathon, promotes autophagy
in progenitor cells in response to oxidative stress, along
with the differentiation process. Indeed, the upregulated
TERT and TERF1 gene expression suggests active recruit-
ment of MSCs and enhanced differentiation ability. The
observed downregulation of DNA repair genes can be
related to autophagy as well [68]. Consequently, prediffer-
entiated cells harboring genome alterations might be elim-
inated, promoting enhanced differentiation of progenitors
after physical activity.
So far, we can conclude that half marathon physical
commitment promotes osteogenic and chondrogenic dif-
ferentiation as well as autophagy, through a complex
biological interplay. Autophagy modulation in MSCs
appears of great interest for new therapeutic approaches.
In fact, autophagy in MSCs enhances their proangiogenic
and immunomodulatory characteristics hence highlighting
their therapeutic potential against several diseases [73].
In this context, our findings disclose novel insights into
the benefits of physical exercise in healthy and chronic
degenerative conditions.
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